A Cytogenetic Abnormality and Rare Coding Variants Identify ABCA13 as a Candidate Gene in Schizophrenia, Bipolar Disorder, and Depression

American Journal of Human Genetics

Volumn 85, Issue 6, 2009, Pages 833-846

  Knight, Helen M ^a   Pickard, Benjamin S ^a   Maclean, Alan ^a   Malloy, Mary P ^a   Soares, Dinesh C ^a   McRae, Allan F ^b   Condie, Alison ^c   White, Angela ^c   Hawkins, William ^c   McGhee, Kevin ^a   van Beck, Margaret ^a   MacIntyre, Donald J ^a   Starr, John M ^a   Deary, Ian J ^a   Visscher, Peter M ^b   Porteous, David J ^a   Cannon, Ronald E ^d   St Clair, David ^e   Muir, Walter J ^a   Blackwood, Douglas H R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; PROCYCLIDINE;

ABCA13 GENE; ADULT; ARTICLE; BIPOLAR DISORDER; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; CYTOGENETICS; DEPRESSION; EXON; GENE; GENE IDENTIFICATION; GENE NUMBER; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA;

AMINO ACID SEQUENCE; ATP-BINDING CASSETTE TRANSPORTERS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CODON, NONSENSE; CYTOGENETICS; DEPRESSION; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; SCHIZOPHRENIA; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 71449105010     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajhg.2009.11.003     Document Type: Article

References (83)

1. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., and Wang P.S. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 (2003) 3095-3105
2. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., and Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373 (2009) 234-239
3. WHO. (2001). World Health Report http://www.who.int/whr/2001/en.
4. Maier W., Lichtermann D., Minges J., Hallmayer J., Heun R., Benkert O., and Levinson D.F. Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Arch. Gen. Psychiatry 50 (1993) 871-883
5. McGuffin P., Rijsdijk F., Andrew M., Sham P., Katz R., and Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch. Gen. Psychiatry 60 (2003) 497-502
6. Kieseppa T., Partonen T., Haukka J., Kaprio J., and Lonnqvist J. High concordance of bipolar I disorder in a nationwide sample of twins. Am. J. Psychiatry 161 (2004) 1814-1821
7. Sullivan P.F., Kendler K.S., and Neale M.C. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60 (2003) 1187-1192
8. Sullivan P.F., Neale M.C., and Kendler K.S. Genetic epidemiology of major depression: Review and meta-analysis. Am. J. Psychiatry 157 (2000) 1552-1562
9. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., Fan J., Kirov G., Perlis R.H., Green E.K., et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 40 (2008) 1056-1058
10. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 40 (2008) 1053-1055
11. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., and Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460 (2009) 748-752
12. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietilainen O.P., Mors O., Mortensen P.B., et al. Common variants conferring risk of schizophrenia. Nature 460 (2009) 744-747
13. Sullivan P.F., de Geus E.J., Willemsen G., James M.R., Smit J.H., Zandbelt T., Arolt V., Baune B.T., Blackwood D., Cichon S., et al. Genome-wide association for major depressive disorder: A possible role for the presynaptic protein piccolo. Mol. Psychiatry 14 (2009) 359-375
14. WTCCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
15. ISC. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455 (2008) 237-241
16. Kirov G., Gumus D., Chen W., Norton N., Georgieva L., Sari M., O'Donovan M.C., Erdogan F., Owen M.J., Ropers H.H., et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum. Mol. Genet. 17 (2008) 458-465
17. Stefansson H., Rujescu D., Cichon S., Pietilainen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., et al. Large recurrent microdeletions associated with schizophrenia. Nature 455 (2008) 232-236
18. Kamnasaran D., Muir W.J., Ferguson-Smith M.A., and Cox D.W. Disruption of the neuronal PAS3 gene in a family affected with schizophrenia. J. Med. Genet. 40 (2003) 325-332
19. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., Malloy M.P., Chubb J.E., Huston E., Baillie G.S., et al. Dros. Inf. Serv.C1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310 (2005) 1187-1191
20. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., Clair D.M., Muir W.J., Blackwood D.H., et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9 (2000) 1415-1423
21. Pickard B.S., Malloy M.P., Christoforou A., Thomson P.A., Evans K.L., Morris S.W., Hampson M., Porteous D.J., Blackwood D.H., and Muir W.J. Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder. Mol. Psychiatry 11 (2006) 847-857
22. Pickard B.S., Malloy M.P., Porteous D.J., Blackwood D.H., and Muir W.J. Disruption of a brain transcription factor, NPAS3, is associated with schizophrenia and learning disability. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 136 (2005) 26-32
23. Pickard B.S., Christoforou A., Thomson P.A., Fawkes A., Evans K.L., Morris S.W., Porteous D.J., Blackwood D.H., and Muir W.J. Interacting haplotypes at the NPAS3 locus alter risk of schizophrenia and bipolar disorder. Mol. Psychiatry 14 (2008) 874-884
24. Pickard B.S., Knight H.M., Hamilton R.S., Soares D.C., Walker R., Boyd J.K., Machell J., Maclean A., McGhee K.A., Condie A., et al. A common variant in the 3′UTR of the GRIK4 glutamate receptor gene affects transcript abundance and protects against bipolar disorder. Proc. Natl. Acad. Sci. USA 105 (2008) 14940-14945
25. Pickard B.S., Thomson P.A., Christoforou A., Evans K.L., Morris S.W., Porteous D.J., Blackwood D.H., and Muir W.J. The PDE4B gene confers sex-specific protection against schizophrenia. Psychiatr. Genet. 17 (2007) 129-133
26. Prades C., Arnould I., Annilo T., Shulenin S., Chen Z.Q., Orosco L., Triunfol M., Devaud C., Maintoux-Larois C., Lafargue C., et al. The human ATP binding cassette gene ABCA13, located on chromosome 7p12.3, encodes a 5058 amino acid protein with an extracellular domain encoded in part by a 4.8-kb conserved exon. Cytogenet. Genome Res. 98 (2002) 160-168
27. Uitto J. The gene family of ABC transporters-novel mutations, new phenotypes. Trends Mol. Med. 11 (2005) 341-343
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (2004), American Psychiatric Association, Washington, DC
29. Endicott J., and Spitzer R.L. A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry 35 (1978) 837-844
30. Deary I.J., Gow A.J., Taylor M.D., Corley J., Brett C., Wilson V., Campbell H., Whalley L.J., Visscher P.M., Porteous D.J., et al. The Lothian Birth Cohort 1936: A study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatr. 7 (2007) 28
31. Reese M.G., Eeckman F.H., Kulp D., and Haussler D. Improved splice site detection in Genie. J. Comput. Biol. 4 (1997) 311-323
32. Altschul S.F., Gish W., Miller W., Myers E.W., and Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215 (1990) 403-410
33. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., and Lipman D.J. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25 (1997) 3389-3402
34. Boeckmann B., Bairoch A., Apweiler R., Blatter M.C., Estreicher A., Gasteiger E., Martin M.J., Michoud K., O'Donovan C., Phan I., et al. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res. 31 (2003) 365-370
35. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., and Higgins D.G. The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25 (1997) 4876-4882
36. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., and Bourne P.E. The Protein Data Bank. Nucleic Acids Res. 28 (2000) 235-242
37. Scheffel F., Demmer U., Warkentin E., Hulsmann A., Schneider E., and Ermler U. Structure of the ATPase subunit CysA of the putative sulfate ATP-binding cassette (ABC) transporter from Alicyclobacillus acidocaldarius. FEBS Lett. 579 (2005) 2953-2958
38. Pei J., and Grishin N.V. MUMMALS: Multiple sequence alignment improved by using hidden Markov models with local structural information. Nucleic Acids Res. 34 (2006) 4364-4374
39. Combet C., Blanchet C., Geourjon C., and Deleage G. NPS@: Network protein sequence analysis. Trends Biochem. Sci. 25 (2000) 147-150
40. Frishman D., and Argos P. Knowledge-based protein secondary structure assignment. Proteins 23 (1995) 566-579
41. Jones D.T. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol. 292 (1999) 195-202
42. McGuffin L.J., Bryson K., and Jones D.T. The PSIPRED protein structure prediction server. Bioinformatics 16 (2000) 404-405
43. Sali A., and Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234 (1993) 779-815
44. Bower M.J., Cohen F.E., and Dunbrack Jr. R.L. Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: A new homology modeling tool. J. Mol. Biol. 267 (1997) 1268-1282
45. Canutescu A.A., Shelenkov A.A., and Dunbrack Jr. R.L. A graph-theory algorithm for rapid protein side-chain prediction. Protein Sci. 12 (2003) 2001-2014
46. Clark M., Cramer R.D., and Vanopdenbosch N. Validation of the general-purpose Tripos 5.2 force-field. J. Comput. Chem. 10 (1989) 982-1012
47. Laskowski R.A., Macarthur M.W., Moss D.S., and Thornton J.M. Procheck-A program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26 (1993) 283-291
48. Fraczkiewicz R., and Braun W. Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules. J. Comput. Chem. 19 (1998) 319-333
49. Tina K.G., Bhadra R., and Srinivasan N. PIC: Protein interactions calculator. Nucleic Acids Res. 35 (2007) W473-W476
50. Abecasis G.R., Cherny S.S., Cookson W.O., and Cardon L.R. Merlin-Rapid analysis of dense genetic maps using sparse gene flow trees. Nat. Genet. 30 (2002) 97-101
51. Kong A., and Cox N.J. Allele-sharing models: LOD scores and accurate linkage tests. Am. J. Hum. Genet. 61 (1997) 1179-1188
52. Ferrer-Costa C., Gelpi J.L., Zamakola L., Parraga I., de la Cruz X., and Orozco M. PMUT: A web-based tool for the annotation of pathological mutations on proteins. Bioinformatics 21 (2005) 3176-3178
53. Ramensky V., Bork P., and Sunyaev S. Human non-synonymous SNPs: Server and survey. Nucleic Acids Res. 30 (2002) 3894-3900
54. Sunyaev S., Ramensky V., and Bork P. Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends Genet. 16 (2000) 198-200
55. Thomas P.D., Campbell M.J., Kejariwal A., Mi H., Karlak B., Daverman R., Diemer K., Muruganujan A., and Narechania A. PANTHER: A library of protein families and subfamilies indexed by function. Genome Res. 13 (2003) 2129-2141
56. Nikaido K., and Ames G.F. One intact ATP-binding subunit is sufficient to support ATP hydrolysis and translocation in an ABC transporter, the histidine permease. J. Biol. Chem. 274 (1999) 26727-26735
57. Zaitseva J., Jenewein S., Jumpertz T., Holland I.B., and Schmitt L. H662 is the linchpin of ATP hydrolysis in the nucleotide-binding domain of the ABC transporter HlyB. EMBO J. 24 (2005) 1901-1910
58. Fishman G.A., Stone E.M., Grover S., Derlacki D.J., Haines H.L., and Hockey R.R. Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch. Ophthalmol. 117 (1999) 504-510
59. Bergen A.A., Plomp A.S., Hu X., de Jong P.T., and Gorgels T.G. ABCC6 and pseudoxanthoma elasticum. Pflugers Arch. 453 (2007) 685-691
60. Barros S.A., Tennant R.W., and Cannon R.E. Molecular structure and characterization of a novel murine ABC transporter, Abca13. Gene 307 (2003) 191-200
61. Blackwood D.H., Fordyce A., Walker M.T., St Clair D.M., Porteous D.J., and Muir W.J. Schizophrenia and affective disorders-Cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: Clinical and P300 findings in a family. Am. J. Hum. Genet. 69 (2001) 428-433
62. Kaminski W.E., Piehler A., and Wenzel J.J. ABC A-subfamily transporters: Structure, function and disease. Biochim. Biophys. Acta 1762 (2006) 510-524
63. Kitiratschky V.B., Grau T., Bernd A., Zrenner E., Jagle H., Renner A.B., Kellner U., Rudolph G., Jacobson S.G., Cideciyan A.V., et al. ABCA4 gene analysis in patients with autosomal recessive cone and cone rod dystrophies. Eur. J. Hum. Genet. 16 (2008) 812-819
64. Slatter T.L., Jones G.T., Williams M.J., van Rij A.M., McCormick S.P., Frikke-Schmidt R., Tybjaerg-Hansen A., and Morison I.M. Novel rare mutations and promoter haplotypes in ABCA1 contribute to low-HDL-C levels. Clin. Genet. 73 (2008) 179-184
65. Albrecht C., and Viturro E. The ABCA subfamily-Gene and protein structures, functions and associated hereditary diseases. Pflugers Arch. 453 (2007) 581-589
66. D'Angelo G., Vicinanza M., and De Matteis M.A. Lipid-transfer proteins in biosynthetic pathways. Curr. Opin. Cell Biol. 20 (2008) 360-370
67. van Meer G., Voelker D.R., and Feigenson G.W. Membrane lipids: Where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9 (2008) 112-124
68. Fitzgerald M.L., Okuhira K., Short III G.F., Manning J.J., Bell S.A., and Freeman M.W. ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activities. J. Biol. Chem. 279 (2004) 48477-48485
69. Doris A.B., Wahle K., MacDonald A., Morris S., Coffey I., Muir W., and Blackwood D. Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia. Schizophr. Res. 31 (1998) 185-196
70. Glen A.I., Glen E.M., Horrobin D.F., Vaddadi K.S., Spellman M., Morse-Fisher N., Ellis K., and Skinner F.S. A red cell membrane abnormality in a subgroup of schizophrenic patients: Evidence for two diseases. Schizophr. Res. 12 (1994) 53-61
71. McNamara R.K., Jandacek R., Rider T., Tso P., Hahn C.G., Richtand N.M., and Stanford K.E. Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: Gender differences and partial normalization with antipsychotic medications. Schizophr. Res. 91 (2007) 37-50
72. McNamara R.K., Jandacek R., Rider T., Tso P., Stanford K.E., Hahn C.G., and Richtand N.M. Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry Res. 160 (2008) 285-299
73. Peet M., Laugharne J., Rangarajan N., Horrobin D., and Reynolds G. Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients. J. Psychiatr. Res. 29 (1995) 227-232
74. Yao J.K., van Kammen D.P., and Gurklis J. Red blood cell membrane dynamics in schizophrenia. III. Correlation of fatty acid abnormalities with clinical measures. Schizophr. Res. 13 (1994) 227-232
75. Georgieva L., Moskvina V., Peirce T., Norton N., Bray N.J., Jones L., Holmans P., Macgregor S., Zammit S., Wilkinson J., et al. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc. Natl. Acad. Sci. USA 103 (2006) 12469-12474
76. Sims R., Hollingworth P., Moskvina V., Dowzell K., O'Donovan M.C., Powell J., Lovestone S., Brayne C., Rubinsztein D., Owen M.J., et al. Evidence that variation in the oligodendrocyte lineage transcription factor 2 (OLIG2) gene is associated with psychosis in Alzheimer's disease. Neurosci. Lett. 461 (2009) 54-59
77. Segal D., Koschnick J.R., Slegers L.H., and Hof P.R. Oligodendrocyte pathophysiology: A new view of schizophrenia. Int. J. Neuropsychopharmacol. 10 (2007) 503-511
78. Sokolov B.P. Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?. Int. J. Neuropsychopharmacol. 10 (2007) 547-555
79. Tkachev D., Mimmack M.L., Huffaker S.J., Ryan M., and Bahn S. Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia. Int. J. Neuropsychopharmacol. 10 (2007) 557-563
80. Narayan S., Head S.R., Gilmartin T.J., Dean B., and Thomas E.A. Evidence for disruption of sphingolipid metabolism in schizophrenia. J. Neurosci. Res. 87 (2008) 278-288
81. Schmitt A., Wilczek K., Blennow K., Maras A., Jatzko A., Petroianu G., Braus D.F., and Gattaz W.F. Altered thalamic membrane phospholipids in schizophrenia: A postmortem study. Biol. Psychiatry 56 (2004) 41-45
82. Bodmer W., and Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet. 40 (2008) 695-701
83. Makinen V.P., Parkkonen M., Wessman M., Groop P.H., Kanninen T., and Kaski K. High-throughput pedigree drawing. Eur. J. Hum. Genet. 13 (2005) 987-989